Assura PLC (AGR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Assura PLC (AGR) has a cash flow conversion efficiency ratio of 0.042x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX68.20 Million ≈ $8.30K USD) by net assets (GBX1.64 Billion ≈ $199.83K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AGR days of operational coverage to measure how many days the company can operate on defensive assets alone.
Assura PLC - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Assura PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Assura PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Assura PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alpcot Holding AB Series B
ST:ALPCOT-B
|
-0.037x |
|
UMS-Neiken Group Bhd
KLSE:7227
|
0.090x |
|
Naos Ex-50 Opportunities Company Ltd
AU:NAC
|
0.047x |
|
Indivior PLC
LSE:INDV
|
-0.612x |
|
Chiangmai Frozen Foods Public Company Limited
BK:CM
|
-0.032x |
|
Financiere Marjos SA
PA:FINM
|
0.147x |
|
Core AI Holdings
NASDAQ:CHAI
|
N/A |
|
Marker Therapeutics Inc
NASDAQ:MRKR
|
-0.149x |
Annual Cash Flow Conversion Efficiency for Assura PLC (2004–2025)
The table below shows the annual cash flow conversion efficiency of Assura PLC from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see Assura PLC (AGR) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | GBX1.64 Billion ≈ $199.83K |
GBX110.50 Million ≈ $13.44K |
0.067x | -3.21% |
| 2024-03-31 | GBX1.47 Billion ≈ $179.23K |
GBX102.40 Million ≈ $12.46K |
0.070x | +17.27% |
| 2023-03-31 | GBX1.59 Billion ≈ $193.15K |
GBX94.10 Million ≈ $11.45K |
0.059x | +12.13% |
| 2022-03-31 | GBX1.79 Billion ≈ $217.74K |
GBX94.60 Million ≈ $11.51K |
0.053x | +4.54% |
| 2021-03-31 | GBX1.53 Billion ≈ $186.24K |
GBX77.40 Million ≈ $9.42K |
0.051x | -0.67% |
| 2020-03-31 | GBX1.30 Billion ≈ $158.46K |
GBX66.30 Million ≈ $8.07K |
0.051x | -10.62% |
| 2019-03-31 | GBX1.28 Billion ≈ $155.73K |
GBX72.90 Million ≈ $8.87K |
0.057x | +42.72% |
| 2018-03-31 | GBX1.25 Billion ≈ $152.14K |
GBX49.90 Million ≈ $6.07K |
0.040x | -16.30% |
| 2017-03-31 | GBX818.00 Million ≈ $99.53K |
GBX39.00 Million ≈ $4.75K |
0.048x | +57.04% |
| 2016-03-31 | GBX754.30 Million ≈ $91.78K |
GBX22.90 Million ≈ $2.79K |
0.030x | -18.82% |
| 2015-03-31 | GBX451.90 Million ≈ $54.98K |
GBX16.90 Million ≈ $2.06K |
0.037x | +7.27% |
| 2014-03-31 | GBX226.60 Million ≈ $27.57K |
GBX7.90 Million ≈ $961.20 |
0.035x | -46.46% |
| 2013-03-31 | GBX198.10 Million ≈ $24.10K |
GBX12.90 Million ≈ $1.57K |
0.065x | -8.69% |
| 2012-03-31 | GBX187.90 Million ≈ $22.86K |
GBX13.40 Million ≈ $1.63K |
0.071x | +449.10% |
| 2011-03-31 | GBX220.13 Million ≈ $26.78K |
GBX2.86 Million ≈ $347.86 |
0.013x | +117.99% |
| 2010-03-31 | GBX162.68 Million ≈ $19.79K |
GBX-11.75 Million ≈ $-1.43K |
-0.072x | -334.57% |
| 2009-03-31 | GBX172.02 Million ≈ $20.93K |
GBX5.29 Million ≈ $644.25 |
0.031x | +227.20% |
| 2008-03-31 | GBX265.38 Million ≈ $32.29K |
GBX-6.42 Million ≈ $-781.37 |
-0.024x | -4444.45% |
| 2006-12-31 | GBX267.50 Million ≈ $32.55K |
GBX149.00K ≈ $18.13 |
0.001x | -91.36% |
| 2006-03-31 | GBX117.93 Million ≈ $14.35K |
GBX760.00K ≈ $92.47 |
0.006x | 0.00% |
| 2005-12-31 | GBX117.93 Million ≈ $14.35K |
GBX760.00K ≈ $92.47 |
0.006x | -59.76% |
| 2005-03-31 | GBX136.75 Million ≈ $16.64K |
GBX2.19 Million ≈ $266.46 |
0.016x | 0.00% |
| 2004-12-31 | GBX136.75 Million ≈ $16.64K |
GBX2.19 Million ≈ $266.46 |
0.016x | -- |
About Assura PLC
Assura plc is the UK's leading diversified healthcare REIT. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served. A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA indices and has a secondary listing on the Johannesburg Stock Exchange. As at 31 March 2025, Assura's portf… Read more